Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma
Status:
Unknown status
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the the efficacy and safety of Anlotinib in combination
with STUPP regimen for patients with newly diagnosed glioblastoma.